Windtree Therapeutics Unveils Bold Revenue Strategy: Plans FDA-Approved Product Acquisitions
Windtree Therapeutics (WINT) has announced a new corporate strategy aimed at becoming a revenue-generating biotech...
Windtree
Windtree Therapeutics Announces New Corporate Strategy Seeking to Identify and Acquire FDA-Approved Revenue Assets While Advancing Its Cardiovascular and Oncology Pipeline
Windtree Therapeutics All-Stock Acquisition Strategy Targets Multiple Small Companies with FDA-Approved Products to Drive Growth and Shareholder Value WARRINGTON, Pa.,...
